Nadia Harbeck, MD, PhD - Antibody-Drug Conjugates in Breast Cancer: Keeping Abreast of the Latest Data As They Emerge From ESMO
Update: 2025-10-30
Description
Visit https://www.peervoice.com/YHE860 to view the entire programme with slides. After completing “Nadia Harbeck, MD, PhD - Antibody-Drug Conjugates in Breast Cancer: Keeping Abreast of the Latest Data As They Emerge From ESMO”, participants will be able to: Evaluate emerging updates on antibody-drug conjugates (ADCs) for the treatment of HER2+ breast cancer; Recall the latest evidence for ADCs in the treatment of HR+ and/or triple-negative breast cancer; and Assess the implications of the latest clinical evidence for approved ADCs in breast cancer in context of current treatment guidelines.
Comments 
In Channel







